---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-031252"
form_type: "8-K"
ticker: "VTAK"
cik: "0001716621"
company_name: "Catheter Precision, Inc."
filed_at: "2026-09-25T21:26:11+00:00"
generated_at: "2026-10-12T13:27:45.736546+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.62
calibrated_materiality_score: 0.62
confidence: "high"
source: SEC EDGAR
---

# Catheter Precision to rename Flyte Aviation and do 1-for-10 reverse split, ticker VJET, effective Oct. 5, 2026

## Summary
- Board approved amendment to change name from Catheter Precision, Inc. to Flyte Aviation, Inc. and effect a 1-for-10 reverse stock split of common stock.
- Reverse split was approved by stockholders at a special meeting held April 15, 2026; the Board selected the ratio within the approved range.
- Name change and split are expected effective at 12:01 a.m. Eastern Time on October 5, 2026; every 10 shares combine into 1 share.
- Common Stock is expected to trade on NYSE American under Flyte Aviation, Inc. and new ticker VJET at market open on October 5, 2026.
- New CUSIP will be 74933X 807; par value and authorized shares are unchanged, and no fractional shares will be issued.

## SEC filing metadata
- accession: 0001437749-26-031252
- form_type: 8-K
- ticker: VTAK
- cik: 0001716621
- company_name: Catheter Precision, Inc.
- filed_at: 2026-09-25T21:26:11+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.62
- calibrated_materiality_score: 0.62
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000143774926031252/0001437749-26-031252-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000143774926031252/vtak20260925_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-031252
- JSON: https://secwatch.observer/filing/0001437749-26-031252.json
- Plain text: https://secwatch.observer/filing/0001437749-26-031252.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.